| abstract |
Disclosed are compounds of Formula I, or salts or prodrugs thereof, complexednwith a human urotensin II receptor as defined herein. Also disclosed are compoundsnof Formula II, or salts or prodrugs thereof, as defined herein. Also disclosednare methods of modulating the activity of a urotensin II receptor using a compoundnof Formula I, or a compound of Formula II, or salts or prodrugs thereof. In addition,nmethods of treating diseases related to the activity of urotensin II receptorsnare disclosed. |